1-12 of 12
Craig A. Beam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Erratum. Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34: 1785–1787

Jay M. Sosenko, Jay S. Skyler, Jeffrey Mahon, Jeffrey P. Krischer, Craig A. Beam, David C. Boulware, Carla J. Greenbaum, Lisa E. Rafkin, Catherine Cowie, David Cuthbertson, Jerry P. Palmer, the Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
Journal: Diabetes Care
Diabetes Care 2018;41(4):913
https://doi.org/10.2337/dc18-er04a
Published: 12 March 2018
View article titled, Erratum. Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34: 1785–1787
Open the PDF for Erratum. Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34: 1785–1787 in another window
Journal Articles

The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months

Jay M. Sosenko, Jay S. Skyler, Craig A. Beam, David Boulware, Jeffrey L. Mahon, Jeffrey P. Krischer, Carla J. Greenbaum, Lisa E. Rafkin, Della Matheson, Kevan C. Herold, Jerry P. Palmer, the Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
Journal: Diabetes Care
Diabetes Care 2015;38(5):940–942
https://doi.org/10.2337/dc14-2787
Published: 10 March 2015
View article titled, The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months
Open the PDF for The Development and Utility of a Novel Scale That Quantifies the Glycemic Progression Toward Type 1 Diabetes Over 6 Months in another window
Includes: Supplementary data
Journal Articles

A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History

Jay M. Sosenko, Jay S. Skyler, Linda A. DiMeglio, Craig A. Beam, Jeffrey P. Krischer, Carla J. Greenbaum, David Boulware, Lisa E. Rafkin, Della Matheson, Kevan C. Herold, Jeffrey Mahon, Jerry P. Palmer, the Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
Journal: Diabetes Care
Diabetes Care 2015;38(2):271–276
https://doi.org/10.2337/dc14-1813
Published: 17 December 2014
View article titled, A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History
Open the PDF for A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History in another window
Includes: Supplementary data
Journal Articles

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes

Jay M. Sosenko, Jay S. Skyler, Jeffrey Mahon, Jeffrey P. Krischer, Carla J. Greenbaum, Lisa E. Rafkin, Craig A. Beam, David C. Boulware, Della Matheson, David Cuthbertson, Kevan C. Herold, George Eisenbarth, Jerry P. Palmer, the Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups
Journal: Diabetes Care
Diabetes Care 2014;37(4):979–984
https://doi.org/10.2337/dc13-2359
Published: 08 March 2014
View article titled, Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes
Open the PDF for Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients

Jay M. Sosenko, MD, Jay S. Skyler, MD, Jerry P. Palmer, MD, Jeffrey P. Krischer, PHD, Liping Yu, MD, Jeffrey Mahon, MD, Craig A. Beam, PHD, David C. Boulware, MS, Lisa Rafkin, MS, Desmond Schatz, MD, George Eisenbarth, MD, the Type 1 Diabetes TrialNet and the Diabetes Prevention Trial–Type 1 Study Groups
Journal: Diabetes Care
Diabetes Care 2013;36(9):2615–2620
https://doi.org/10.2337/dc13-0425
Published: 13 August 2013
View article titled, The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients
Open the PDF for The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients in another window
Includes: Supplementary data
Journal Articles

Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis

Ping Xu, MPH, Craig A. Beam, PHD, David Cuthbertson, MS, Jay M. Sosenko, MD, Jay S. Skyler, MD, Jeffrey P. Krischer, PHD, the DPT-1 Study Group
Journal: Diabetes Care
Diabetes Care 2012;35(10):1975–1980
https://doi.org/10.2337/dc12-0183
Published: 11 September 2012
View article titled, Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: <subtitle>Receiver operating characteristic analysis</subtitle>
Open the PDF for Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: <subtitle>Receiver operating characteristic analysis</subtitle> in another window
Includes: Supplementary data
Journal Articles

Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth

Kendra Vehik, PHD, David Cuthbertson, MS, David Boulware, MS, Craig A. Beam, PHD, Henry Rodriguez, MD, Laurent Legault, MD, Mila Hyytinen, PHD, Marian J. Rewers, MD, Desmond A. Schatz, MD, Jeffrey P. Krischer, PHD, the TEDDY, TRIGR, Diabetes Prevention Trial–Type 1, and Type 1 Diabetes TrialNet Natural History Study Groups
Journal: Diabetes Care
Diabetes Care 2012;35(9):1821–1825
https://doi.org/10.2337/dc12-0111
Published: 14 August 2012
View article titled, Performance of HbA<sub>1c</sub> as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth
Open the PDF for Performance of HbA<sub>1c</sub> as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth in another window
Includes: Supplementary data
Journal Articles

The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes

Jay M. Sosenko, MD, Jay S. Skyler, MD, Jeffrey Mahon, MD, Jeffrey P. Krischer, PHD, Craig A. Beam, PHD, David C. Boulware, MS, Carla J. Greenbaum, MD, Lisa E. Rafkin, MS, Catherine Cowie, PHD, David Cuthbertson, MS, Jerry P. Palmer, MD, the Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
Journal: Diabetes Care
Diabetes Care 2012;35(7):1552–1555
https://doi.org/10.2337/dc12-0011
Published: 12 June 2012
View article titled, The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes
Open the PDF for The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes in another window
Journal Articles

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies

Liping Yu, MD, David C. Boulware, MS, Craig A. Beam, PHD, John C. Hutton, PHD, Janet M. Wenzlau, PHD, Carla J. Greenbaum, MD, Polly J. Bingley, MD, Jeffrey P. Krischer, PHD, Jay M. Sosenko, MD, Jay S. Skyler, MD, George S. Eisenbarth, MD, Jeffrey L. Mahon, MD, for the Type 1 Diabetes TrialNet Study Group
Journal: Diabetes Care
Diabetes Care 2012;35(6):1213–1218
https://doi.org/10.2337/dc11-2081
Published: 11 May 2012
View article titled, Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies
Open the PDF for Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies in another window
Includes: Supplementary data
Journal Articles

Development of Autoantibodies in the TrialNet Natural History Study

Kendra Vehik, PHD, Craig A. Beam, PHD, Jeffrey L. Mahon, MD, Desmond A. Schatz, MD, Michael J. Haller, MD, Jay M. Sosenko, MD, Jay S. Skyler, MD, Jeffrey P. Krischer, PHD, for the TrialNet Natural History Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(9):1897–1901
https://doi.org/10.2337/dc11-0560
Published: 19 August 2011
View article titled, Development of Autoantibodies in the TrialNet Natural History Study
Open the PDF for Development of Autoantibodies in the TrialNet Natural History Study in another window
Journal Articles

Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study

Jay M. Sosenko, MD, Jay S. Skyler, MD, Jeffrey Mahon, MD, Jeffrey P. Krischer, PHD, Craig A. Beam, PHD, David C. Boulware, MS, Carla J. Greenbaum, MD, Lisa E. Rafkin, MS, Catherine Cowie, PHD, David Cuthbertson, MS, Jerry P. Palmer, MD, the Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
Journal: Diabetes Care
Diabetes Care 2011;34(8):1785–1787
https://doi.org/10.2337/dc11-0641
Published: 16 July 2011
View article titled, Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study
Open the PDF for Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study in another window
Includes: Supplementary data
Journal Articles

Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood

Kendra Vehik, PHD, Michael J. Haller, MD, Craig A. Beam, PHD, Desmond A. Schatz, MD, Diane K. Wherrett, MD, Jay M. Sosenko, MD, Jeffrey P. Krischer, PHD, DPT-1 Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(2):358–362
https://doi.org/10.2337/dc10-1494
Published: 20 January 2011
View article titled, Islet Autoantibody Seroconversion in the DPT-1 Study: <subtitle>Justification for repeat screening throughout childhood</subtitle>
Open the PDF for Islet Autoantibody Seroconversion in the DPT-1 Study: <subtitle>Justification for repeat screening throughout childhood</subtitle> in another window